Načítá se...
Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges
The negative efficacy outcomes of double-blinded, randomized, placebo-controlled Phase III human clinical trials with selenomethionine (SeMet) and SeMet-rich selenized-yeast (Se-yeast) for prostate cancer prevention and Se-yeast for prevention of non-small cell lung cancer (NSCLC) in North America l...
Uloženo v:
| Vydáno v: | Nutr Cancer |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4822195/ https://ncbi.nlm.nih.gov/pubmed/26595411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/01635581.2016.1105267 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|